Omeros Corporation
OMER
#6820
Rank
C$1.02 B
Marketcap
C$14.11
Share price
14.30%
Change (1 day)
245.65%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.23 Billion a decrease over its 2023 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion-25.01%
2024 -C$0.23 Billion9.63%
2023 -C$0.21 Billion-9.57%
2022 -C$0.23 Billion-30.65%
2021 -C$0.33 Billion86.28%
2020 -C$0.18 Billion99.45%
2019 -C$88.03 Million-49.91%
2018 -C$0.18 Billion190.77%
2017 -C$60.44 Million-27.96%
2016 -C$83.89 Million-17.61%
2015 -C$0.11 Billion1.88%
2014 -C$99.95 Million87.56%
2013 -C$53.29 Million
2011 -C$39.03 Million-8.96%
2010 -C$42.86 Million45.03%
2009 -C$29.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.98 B-21,832.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$15.07 B-8,959.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-C$5.51 Million-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-C$13.51 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA